FAQ
Q: Does "inflammation subsides" equate to "inflammatory factors decrease"?
+
A: Not equivalent. A decrease in inflammatory cytokines may indicate
resolution, but it could also be due to immune suppression or missing the sampling window. It is
recommended to compare resolution/negative feedback markers (such as IL-10, IL-1RA, TGF-β1) with the
pro-inflammatory background (e. g., TNF-α/IL-6) to avoid misinterpreting "suppression" as "successful
resolution."
Q: How do I determine if the model has transitioned from the "inflammatory phase" to the "repair
phase"?
+
A: Typically, it is necessary to observe changes in two types of signals:
- Signs of easing are beginning to emerge. (such as IL-10, IL-1RA,
TGF-β1 rising/becoming dominant)
- Driver Enhancement Repair (such as VEGF, PDGF, and other factors
related to angiogenesis/tissue remodeling begin to rise)
If there is only a subsiding signal without a repair signal, it may indicate
"inflammation subsiding but insufficient repair."
Q: Why does Topic 5 simultaneously emphasize "repair" and "fibrosis risk"?
+
A: Fibrosis can be understood as "uncontrolled repair." Certain repair
factors (particularly TGF-β1) are involved in both repair processes and scar/fibrosis formation. Using a
panel to simultaneously observe "repair-driven" and "pro-fibrotic-driven" mechanisms can better address
the question: Is it recovering, or is it heading towards scarring?
Q: Does TGF-β1 represent "repair" or "fibrosis"?
+
A: It's difficult to draw a conclusion based solely on TGF-β1. It is
recommended to interpret it within a combination:
- and VEGF/PDGFS imultaneous Rise: Indicates entry into the
repair/reconstruction process (but still requires attention to scar risk)
- and TIMP-1, IL-13 Concurrent elevation of pro-fibrotic signals: more
akin to "enhanced fibrotic propensity."
Therefore, Topic 5 places TGF-β1 in different contexts to provide you with a
"contextualized interpretation."
Q: If I can only choose 2 indicators, how can I make a more stable selection?
+
A: As per your requestMost concerned decision-making issues selected:
- Has it entered the subsidence phase? IL-10 + IL-1RA
- Has it entered the recovery phase? VEGF-A + TGF-β1
- Is ECM remodeling imbalanced? MMP-9 + TIMP-1
- Is the risk of fibrosis increased? TGF-β1 + PDGF-BB
Q: Why use MMP-9 + TIMP-1 to examine ECM remodeling?
+
A: The core of ECM remodeling lies in the balance between "degradation vs.
inhibition": MMP-9 represents the capacity for matrix degradation, while TIMP-1 represents its
inhibition. The combination of the two is more suitable for "trend assessment and stratification,"
making it less prone to misjudging the remodeling state compared to examining either one alone.
Q: Should I use serum/plasma or tissue homogenate for repair and fibrosis assessment?
+
A:
- Serum/Plasma More suitable for overall trend and cohort comparisons
(commonly used in efficacy/toxicity studies).
- Tissue homogenate/lysis buffer More suitable for reflecting the local
repair/fibrotic environment (such as in organs like the lungs, liver, kidneys, heart, etc.)
If you are concerned about "whether local tissue is progressing towards
fibrosis," tissue samples are generally more sensitive, but attention should be paid to
normalization and matrix interference.
Q: How to choose the time point? Why can't I detect changes in VEGF or MMP/TIMP?
+
A: Repair and reshaping are often not early events:
- Recession signal Often more pronounced after the peak of
pro-inflammatory response (hours to 1–3 days).
- Repair/Angiogenesis Often more pronounced within 2–7 days.
- ECM Remodeling/Fibrosis Trend More pronounced on daily to weekly
scales.
If only early time points are collected, the peak of repair/remodeling might
be missed.
Q: What does it indicate when IL-10 or IL-1RA is elevated but IL-6 remains high?
+
A: Commonly seen in the transitional phase of "inflammation coexisting with
resolution": the system has initiated braking, but the inflammatory burden remains high. In such cases,
it is advisable to simultaneously assess indicators related to "repair/remodeling" to determine whether
effective repair has begun or if the system is still in a phase of ongoing damage.
